|Return to Archived Newletter Index
|Vol. 4 Issue 5
IN THIS ISSUE:
FIRST HUMAN IMPLANT OF TALENT" COMPLETED.
U.S. PATENT FOR METHOD OF MANUFACTURING.
PRODUCTION OUTPUT UP OVER 100%.
EDITORIAL AND EXHIBIT SCHEDULE.
November 1995 production output of their modilution catheters was over 100% (2X) higher than the same month of the previous year and over 30% above the previous month, which up until then was the record month for production.
The company now maintains two full staff full-time shifts and is in the process of adding space and equipment for additional production capacity. Evan with the high gains in production output, the sales growth still exceeds output resulting in a back order situation of 8-10 weeks. The sales have been bolstered for our patented POLYURETHANE balloon catheters with increased awareness in the market of severe allergic reactions to our competitors LATEX balloon catheters.
First Human Implant of TALENT" System Done in Australia as Planned!
Exemption from Registration was arranged by World Medical Australasia and Dr. Ken Thomson of the Royal Melbourne Hospital with the Therapeutic Goods Administration (T.G.A.-the Australian equivalent of ED.A.) - With I.P.U. (Individualized patient use) #694/95 the procedure was authorized in the proper manner.
Method of Manufacturing Polyurethane Balloons
Adding to the company's building portfolio of important patents, the firm has received notice of allowance from the U.S. Patent Office regarding it's application for method of manufacturing polyurethane balloons.
The company has a number of applications pending including those covering:PRO-CELL" protruding needle catheter and intravascular-vibrational system.
|TOP OF PAGE | NEXT PAGE